22nd Century Group to Announce First Quarter 2020 Financial Results on May 7, 2020
28 avr. 2020 06h50 HE
|
22nd Century Group, Inc.
Williamsville, NY, April 28, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced...
FDA Announces Deadline to Submit Comments on 22nd Century Group’s MRTP Application
17 avr. 2020 12h15 HE
|
22nd Century Group, Inc.
WILLIAMSVILLE, NY, April 17, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced...
22nd Century Group to Hold Virtual Annual Meeting of Stockholders
08 avr. 2020 16h15 HE
|
22nd Century Group, Inc.
Williamsville, NY, April 08, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced...
22nd Century Announces Important New Achievements with KeyGene
11 mars 2020 16h15 HE
|
22nd Century Group, Inc.
Delivers Complete High-Quality Hemp/Cannabis Genome Sequence; Establishes New Proprietary Hemp/Cannabis Bioinformatics Platform WILLIAMSVILLE, N.Y. , March 11, 2020 (GLOBE NEWSWIRE) -- 22nd Century...
22nd Century Group Adds to Leadership Team
10 mars 2020 16h15 HE
|
22nd Century Group, Inc.
WILLIAMSVILLE, N.Y., March 10, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis...
CORRECTION: Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use of Very Low Nicotine Content Cigarettes Does Not Lead to Compensatory Smoking
04 mars 2020 13h03 HE
|
22nd Century Group, Inc.
Williamsville, NY, March 04, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE AMERICAN: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis...
Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use
04 mars 2020 06h50 HE
|
22nd Century Group, Inc.
Williamsville, NY, March 04, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE AMERICAN: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis...
22nd Century Group Appoints New Director and New Chairman
13 janv. 2020 06h45 HE
|
22nd Century Group, Inc.
Williamsville, NY, Jan. 13, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine...
22nd Century Group to Present its Modified Risk Tobacco Product Application to FDA’s Tobacco Products Scientific Advisory Committee
23 déc. 2019 15h39 HE
|
22nd Century Group, Inc.
Williamsville, NY, Dec. 23, 2019 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine...
FDA Authorizes Marketing of 22nd Century Group’s Proprietary Moonlight® and Moonlight® Menthol Cigarettes
17 déc. 2019 13h34 HE
|
22nd Century Group, Inc.
Williamsville, NY, Dec. 17, 2019 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine...